Nextcure

Developer of next-generation immuno-oncology-based drugs

placeNew Haven, Connecticut, United States calendar_todayFounded 2015 groups87 employees language nextcure.com

Registered entities

Innovation

15 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,684 times.

YearFilings
20182
20194
20203
20215
20222
20234
20248
202510
20261

Investor mix

21 investors on record; lead investors include Canaan, Lilly Asia Ventures, Orbimed, Sofinnova Investments.

Investor typeCountShare
Venture capital1152%
Private equity210%
Angel & family office15%
Other / undisclosed733%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

31 Mar 2026 · Director, Clinical Development (Clinical Trial Physician) · Riverdale Park

Based on job postings tracked across public sources.

Coming soon